Probiotics Before Surgery: A Result Strong Enough to Take Seriously, and Narrow Enough to Interpret Carefully

Most of the probiotic research I read comes out somewhere between "possibly helpful" and "we cannot tell." So when a review reports a halving of infection risk and grades its own evidence as high certainty, that gets my attention. A new umbrella review did exactly that, and the population it studied is a specific one: people having gastrointestinal and cancer-related surgery [1].

Image by bzwei via Pixabay

What the umbrella review found

An umbrella review is a review of other reviews. Rather than pooling individual trials, the authors gather the existing meta-analyses on a question and assess how trustworthy the whole body of work is. This one, published in Clinical Nutrition ESPEN, pulled together 34 meta-analyses (studies that pool the results of many trials) covering 52 clinical trials and 4,101 participants, then recalculated the effect sizes and graded the certainty of evidence using GRADE, the standard tool for that job [1].

Two outcomes were assessed. For postoperative infection, probiotics were associated with a relative risk of 0.51 compared with placebo, which is roughly half the risk, with a confidence interval of 0.40 to 0.64. That interval is the range the true effect most likely falls within. The heterogeneity statistic was zero percent, meaning the included studies found consistent results, and the authors graded that finding as high certainty. Synbiotics, which combine probiotic organisms with the fibers that feed them, were associated with a relative risk of 0.64, graded moderate certainty.

For length of antibiotic use, the numbers looked good and the certainty did not. Probiotics were associated with 1.77 fewer days of antibiotics and synbiotics with 3.56 fewer days, but heterogeneity ran extremely high, at 98 percent and 91 percent respectively, and the authors graded both findings as low certainty. When studies disagree that much, the pooled average is a calculation across very different results, and it cannot predict what would happen to any given patient.

So this paper supports two different conclusions. The infection finding is well supported. The antibiotic-duration finding is an early signal, and the low-certainty grade means nobody should draw a firm conclusion from it yet.

Who these results apply to, and the safety side

The authors are careful about generalizing, and they flag the population themselves: these results come predominantly from cancer and gastrointestinal surgery patients [1]. That is a group with a particular set of exposures, including bowel preparation, surgical opening of the gut, and antibiotics given around the time of the operation. The reason a probiotic might plausibly help there does not automatically transfer to a healthy person taking a capsule at home.

There is a safety literature here too, and it belongs alongside the studies of whether probiotics work. A review in Clinical Infectious Diseases laid out the theoretical risks that have been described in case reports and experimental work, including systemic infection, and made the point that safety outcomes are inconsistently reported across probiotic trials [2]. A separate retrospective study identified 10 cases of Saccharomyces cerevisiae fungemia, a bloodstream infection with the yeast used in S. boulardii products [3]. Eighty percent of those patients were being fed by IV or by tube (parenteral or enteral nutrition), 70 percent had a central venous line (a catheter placed in a large vein), and six had been prescribed an S. boulardii-containing probiotic. Half of them died. The authors concluded that beyond the recognized risk factors, advanced age should also be treated as a contraindication, meaning a reason to avoid the product.

Those cases are rare, and they come from exactly the setting this umbrella review studied: hospitalized people, often with catheters and compromised barriers. Both things are true at once. In a supervised surgical protocol the benefit can outweigh that risk, and the same organism in the same patient without supervision is a different proposition.

Why strain and setting change the answer

This result is more favorable to a supplement than I usually get to report, and I don't want to overstate it.

This research did not test whether probiotics help with infections generally. The trials gave specific formulations, around a specific surgery, to a specific population, and found a reduction in a specific outcome. Compare it with the constipation literature, where a meta-analysis of 30 probiotic trials found that Bifidobacterium lactis improved stool frequency while mixtures of probiotics and two other named strains did not [4]. Different strains do different things, and a result in one indication is a poor guide to another.

This is where I end up with most microbiome questions. The intervention is the organism, the dose, the timing, and the person receiving it, much more than the category label on the bottle, and my job in practice is usually to slow that decision down rather than speed it up. I stage these things deliberately, and around surgery I want the surgical team making the call rather than working around them. That is how I practice; it is not a protocol anyone has trialed against an alternative.

Where a halved infection risk does and does not apply

1. Bring it up with your surgical team rather than deciding alone. This research describes supervised perioperative protocols, and your team knows your catheters, your immune status, and what the rest of your medication list looks like.

2. Say what you are already taking. Many people do not think of a probiotic as something to mention before an operation. Given the fungemia cases described above [3], it is.

3. Expect strain-level specificity. If your team is open to this, the useful question is which organism and which timing, because "a probiotic" is not one thing [4].

4. Note which finding is well supported. The infection reduction is the well-supported finding. The shorter antibiotic courses were graded low certainty [1], so do not plan around them.

5. Be more cautious, not less, if you are immunocompromised, have a central line, are on tube or IV feeding, or are older. These are the circumstances in which the reported harms occurred [3].

Research this favorable to a nutritional intervention is not something I get to write about often. The most useful thing I can do with it is describe what it actually showed, in the population where it showed it, instead of stretching it into a general recommendation it cannot support.

References

Primary research located and verified via PubMed.

1. Zanganeh AH, Moghaddas Kia E, Mehrabani S, et al. Efficacy of probiotic and synbiotic supplementation on antibiotic use duration and risk of postoperative infection in patients undergoing gastrointestinal and cancer-related surgery: An umbrella review of meta-analyses. Clin Nutr ESPEN. 2026;75:105013. PMID 42600939. https://doi.org/10.1016/j.clnesp.2026.105013 (digest source article)

2. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60(Suppl 2):S129-S134. PMID 25922398. https://doi.org/10.1093/cid/civ085

3. Poncelet A, Ruelle L, Konopnicki D, Miendje Deyi VY, Dauby N. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration. Infect Dis Now. 2021;51(3):293-295. PMID 33934809. https://doi.org/10.1016/j.idnow.2020.12.003

4. van der Schoot A, Helander C, Whelan K, Dimidi E. Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2022;41(12):2759-2777. PMID 36372047. https://doi.org/10.1016/j.clnu.2022.10.015 (held in the Yggdrasil Abstract Library)

A note before you go

This article is educational and is not medical advice. It describes infection risk around an operation and says nothing about treating cancer or any other underlying condition. Nothing here is a recommendation to start or stop a supplement before a procedure, and the safest version of this conversation is the one you have with your surgical team while the plan is still being made. If you are already taking a probiotic and surgery is coming, the single most useful thing you can do is tell them.

---

If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.